Averride MP 2mg/500mg/15mg Tablet SR
Marketer
Altrawell Biotech Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Averride MP 2mg/500mg/15mg Tablet SR
A single tablet of Glycotrim-MP (2mg/500mg/15mg sustained-release) combines medications to manage blood glucose. This formulation, used alongside diet and exercise, improves glycemic control in adult patients with type 2 diabetes. It enhances insulin effectiveness, consequently reducing blood sugar. Adhere strictly to your physician's prescribed dosage and regimen for Glycotrim-MP. Ingest it with food to minimize gastrointestinal discomfort. If a dose is missed, take it immediately; however, if nearing the next scheduled dose, omit the missed one and resume your usual schedule. Never double the dose. An overdose can trigger hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Common adverse reactions may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating Glycotrim-MP, disclose any existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Renal function assessment will be performed before treatment commences. Limit alcohol consumption, as it may heighten the risk of side effects.
Primary Ingredients of Averride MP 2mg/500mg/15mg Tablet SR
No text provided to rephrase.
Uses of Averride MP 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Averride MP 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Averride MP 2mg/500mg/15mg Extended-Release Tablets should be administered with food.
Common Side effects of Averride MP 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Averride MP 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or divide it. Averride MP 2mg/500mg/15mg Extended-Release Tablets should be administered with a meal.
How Averride MP 2mg/500mg/15mg Tablet SR works:
Averride MP 2mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach enhances blood glucose management when single or dual therapies prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Averride MP 2mg/500mg/15mg SR tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The extended-release Averride MP tablet (2mg/500mg/15mg) might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Averride MP tablets (2mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available evidence indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Averride MP 2mg/500mg/15mg SR tablets, as dose modification may be necessary. Severe kidney disease contraindicates the use of Averride MP 2mg/500mg/15mg SR tablets. Physician consultation is recommended. Routine monitoring of kidney function is advised during treatment with this medication.
LiverCAUTION
Patients with liver impairment should use Averride MP 2mg/500mg/15mg SR tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. The use of Averride MP 2mg/500mg/15mg SR tablets is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Averride MP 2mg/500mg/15mg Tablet SR :
Should you forget to take your Averride MP 2mg/500mg/15mg Tablet SR, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Averride MP 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Medication for diabetes |
3,018 People bought this recently